An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes
NCT01022112
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
383
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
TA-7284-Low
DRUG:
TA-7284-Low-middle
DRUG:
TA-7284-High-middle
DRUG:
TA-7284-High
DRUG:
Placebo
Sponsor
Tanabe Pharma Corporation